US$ 21.50
glutathione parkinson's disease therapy perlmutter Scientists found the protein that spreads — and we have a drug that blocks it. Scientists have identified a critical protein partnership that spreads Parkinson's through the brain, and an Enhanced accumulation of reduced glutathione
Description
Insulin receptor substrate (IRS)-2, not IRS-1, protects human neuroblastoma cells against apoptosis

BPC-157 and TB-500 capsules are easy to take, eliminating the need for injections or nasal administration

Extensive evidence highlights its key safety characteristics: No genotoxic or mutagenic activity: The JofEM study [2] on AOD 9604 reported no genotoxic effects in rats and cynomolgus monkeys during Ames, chromosomal aberration, and bone micronucleus assays

If the microbiome is out of balance, it will be that much more difficult to absorb nutrients from food
